pharma · Cystic Fibrosis · Rheumatoid Arthritis · LKFT
Lakefront Biotherapeutics NV
LAVA Therapeutics N.V is a pharma organization headquartered in Utrecht, NL. It trades on NYSE under ticker LKFT. Primary therapeutic focus areas include Cystic Fibrosis, Rheumatoid Arthritis, Ulcerative Colitis, Idiopat
Yalelaan 60, 5th floor, Utrecht 3584 CM, NL HQ
2016 Founded
9 Employees
Public company Type
LKFT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Yalelaan 60, 5th floor, Utrecht 3584 CM, NL
- Founded
- 2016
- Employees
- 9
- Programs
- 99
- Drugs
- 26
- Patents
- 0
GLPG5101
Phase 2 · gene therapy · Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
GLPG5101 for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma is a Phase 2 program (gene_therapy) at Lakefront Biotherapeutics NV with 1 ClinicalTrials.gov record(s).
Internal code CP0201-NHL
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Lakefront Biotherapeutics NV
- Phase
- Phase 2
- Modality
- gene_therapy
- Indication
- Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
- Status
- active
- Trials
- 1